The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 28, 2024

Filed:

May. 14, 2020
Applicant:

Beijing Luzhu Biotechnology Co., Ltd., Beijing, CN;

Inventors:

Jian Kong, Beijing, CN;

Pei Hong Jiang, Beijing, CN;

Ling Peng, Beijing, CN;

Shuai Yang, Beijing, CN;

Leitao Xu, Beijing, CN;

Kun Zhang, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 9/19 (2006.01); A61K 39/25 (2006.01); A61K 39/39 (2006.01); A61P 31/22 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 9/19 (2013.01); A61K 39/25 (2013.01); A61K 39/39 (2013.01); A61P 31/22 (2018.01); A61K 2039/5254 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/6056 (2013.01); C07K 2319/30 (2013.01); C12N 2710/16722 (2013.01); C12N 2710/16734 (2013.01);
Abstract

The present disclosure discloses a recombinant varicella-zoster virus (VZV) vaccine, including a fusion protein formed by an amino acid sequence of an extracellular domain of a recombinant glycoprotein gE of a live attenuated VZV strain (OKA strain) gene and an Fc fragment of human immunoglobulin. The present disclosure further provides preparation and use of the fusion protein, a corresponding recombinant gene, a eukaryotic expression vector, etc. The fusion protein of the present disclosure has prominent immunogenicity and can induce the high-level expression of neutralizing antibodies in serum.


Find Patent Forward Citations

Loading…